[
  {
    "ts": null,
    "headline": "Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?",
    "summary": "HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.",
    "url": "https://finnhub.io/api/news?id=8df2967993ccaba27de452a17584b35aedf13d852173aca45f61e3cedb8ce6e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754656980,
      "headline": "Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?",
      "id": 136266976,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.",
      "url": "https://finnhub.io/api/news?id=8df2967993ccaba27de452a17584b35aedf13d852173aca45f61e3cedb8ce6e3"
    }
  },
  {
    "ts": null,
    "headline": "There May Be Some Bright Spots In Hologic's (NASDAQ:HOLX) Earnings",
    "summary": "NasdaqGS:HOLX 1 Year Share Price vs Fair Value Explore Hologic's Fair Values from the Community and select yours The...",
    "url": "https://finnhub.io/api/news?id=5fe9208d96d14ec842982b39602c9e3b6b514e368594080429977dd7ea4c109a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754648867,
      "headline": "There May Be Some Bright Spots In Hologic's (NASDAQ:HOLX) Earnings",
      "id": 136268006,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "NasdaqGS:HOLX 1 Year Share Price vs Fair Value Explore Hologic's Fair Values from the Community and select yours The...",
      "url": "https://finnhub.io/api/news?id=5fe9208d96d14ec842982b39602c9e3b6b514e368594080429977dd7ea4c109a"
    }
  }
]